October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming ...
Today the American College of Rheumatology (ACR) announced the appointment of Hospital for Special Surgery (HSS) ...
During Q3, there was a 31% year-over-year increase in job postings live on BioSpace. The number of employees affected by ...
Gerard Michel, Chief Executive Officer of Delcath Systems, Inc. and Dr. Sachin Modi, Consultant Interventional Radiologist at ...
If approved, detalimogene would be the first and only non-viral plasmid gene therapy suitable for integration into any ...
Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the ...
Cumulative prescribers reached 2,410, exceeding the Company’s original full-year 2026 goal of approximately 2,000 a quarter ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...
At the same time, Jason Duncan brings to us a rare combination of legal, governance and operational experience helping scale ...
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of ...
Nearly three times as many patients taking Taltz and Zepbound achieved ≥50% reduction in psoriatic arthritis disease activity ...
Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra-long-acting semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results